Search research articles
Contact Us
Filters
Showing results (1-10 of 162) with videos related to
Page
of 17
Sort By:
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Prognostic factors in elderly patients with AML and the implications for treatment
Harry P Erba
Current Hematology Reports
|
December 30, 2003
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia
Harry P Erba
American Journal of Hematology
|
November 21, 2014
Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: importance of achieving treatment-free remission
Harry P Erba
Future Oncology (London, England)
|
December 4, 2024
A study to learn how well quizartinib with chemotherapy works and how safe it is in people with acute myeloid leukemia that is FLT3-ITD-positive: a plain language summary of the QuANTUM-First study
Harry P Erba
Leukemia Research
|
January 12, 2015
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy
Harry P Erba
Best Practice & Research. Clinical Haematology
|
December 7, 2010
Has there been progress in the treatment of older patients with acute myeloid leukemia?
Harry P Erba
Annali Di Ostetricia, Ginecologia, Medicina Perinatale
|
July 1, 1991
[Florid vulvar condylomatosis. Comparison of therapeutic schedules]
V Bianco, P Erba, G Remotti
American Journal of Hematology
|
February 17, 2025
Frontline Therapy of AML in the Fit and Younger Population-Incorporating Molecularly Targeted Agents
Keith W Pratz, Harry P Erba
American Journal of Clinical Pathology
|
September 1, 2020
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC)
Daniel A Arber, Harry P Erba
Seminars in Hematology
|
March 31, 2019
Shifting paradigms in the treatment of older adults with AML
Thomas W LeBlanc, Harry P Erba
Page
of 17
Search research articles
Search
Showing results (1-10 of 162) with videos related to
Sort By:
Page
of 17
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Prognostic factors in elderly patients with AML and the implications for treatment
Harry P Erba
Current Hematology Reports
|
December 30, 2003
Treatment options for newly diagnosed patients with chronic lymphocytic leukemia
Harry P Erba
American Journal of Hematology
|
November 21, 2014
Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: importance of achieving treatment-free remission
Harry P Erba
Future Oncology (London, England)
|
December 4, 2024
A study to learn how well quizartinib with chemotherapy works and how safe it is in people with acute myeloid leukemia that is FLT3-ITD-positive: a plain language summary of the QuANTUM-First study
Harry P Erba
Leukemia Research
|
January 12, 2015
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy
Harry P Erba
Best Practice & Research. Clinical Haematology
|
December 7, 2010
Has there been progress in the treatment of older patients with acute myeloid leukemia?
Harry P Erba
Annali Di Ostetricia, Ginecologia, Medicina Perinatale
|
July 1, 1991
[Florid vulvar condylomatosis. Comparison of therapeutic schedules]
V Bianco, P Erba, G Remotti
American Journal of Hematology
|
February 17, 2025
Frontline Therapy of AML in the Fit and Younger Population-Incorporating Molecularly Targeted Agents
Keith W Pratz, Harry P Erba
American Journal of Clinical Pathology
|
September 1, 2020
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC)
Daniel A Arber, Harry P Erba
Seminars in Hematology
|
March 31, 2019
Shifting paradigms in the treatment of older adults with AML
Thomas W LeBlanc, Harry P Erba
Page
of 17